✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Camptothecin is an investigational drug.
There have been 146 clinical trials for Camptothecin. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2006.
The most common disease conditions in clinical trials are Neoplasms, Adenocarcinoma, and Colorectal Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), Astex Pharmaceuticals, and Astex Pharmaceuticals, Inc.
Recent Clinical Trials for Camptothecin
|FOLFIRINOX + NIS793 in Pancreatic Cancer||Novartis||Phase 1|
|FOLFIRINOX + NIS793 in Pancreatic Cancer||Colin D. Weekes, M.D.||Phase 1|
|EP0057 in Combination With Olaparib in Relapsed Advanced Gastric Cancer and Small Cell Lung Cancer||Ellipses Pharma||Phase 2|